Key Takeaways
- Amoéba received the gold medal at the SIVAL Innovation 2026 Competition for its biocontrol solution.
- The company confirmed plans to commercially launch its solution in 2026 with partner Koppert.
- AXPERA, to be marketed as TIAGAN for viticulture, targets vineyards and vegetable crops.
- The solution has gained regulatory, commercial, and industry recognition across Europe and the U.S.
- Amoéba is preparing production scale-up ahead of expected market authorisations in 2026.
Amoéba Recognised at SIVAL for Biocontrol Innovation
Amoéba, a France-based greentech company specialising in microbiological solutions using patented amoebae technology, has recapped its participation at SIVAL, the International Exhibition of Plant Production Techniques held in Angers. During the event, Amoéba was awarded the gold medal in the SIVAL Innovation 2026 Competition for its biocontrol solution AXPERA, presented in the category “plant health, soil and growing media.”
The jury evaluated 34 innovations across seven categories, with AXPERA recognised for its scientific approach to sustainable fungal disease control. The award was presented on 14 January during a dedicated ceremony.
“Receiving the SIVAL d'Or in Angers a few months after receiving the Bernard Blum Award in Basel is a source of great pride for the Amoéba teams,” said Jean-François Doucet, CEO of Amoéba. “We must make these effective alternatives available to farmers.”
